Gelteq and Healthy Extracts Form Strategic Partnership to Scale Gel-Based Nutraceutical Manufacturing
核心洞察
Gelteq Limited (搜索) and Healthy Extracts Inc. (搜索) signed a Memorandum of Understanding to accelerate commercial rollout of next-generation gel-based nutraceutical products (搜索) through strategic manufacturing partnership.
The collaboration combines Gelteq's proprietary gel delivery technology (搜索) with Healthy Extracts' US-based manufacturing capabilities to enable large-scale production and global distribution.
Healthy Extracts will serve as primary manufacturer and distributor while Gelteq retains intellectual property ownership, targeting rapidly scalable production to meet growing global demand.
Gelteq Limited (搜索) and Healthy Extracts Inc. (搜索) announced the signing of a Memorandum of Understanding on February 11, 2026, establishing a strategic partnership designed to accelerate the commercial rollout of next-generation gel-based nutraceutical products (搜索). The collaboration builds on Healthy Extracts' prior purchases of Gelteq-formulated products and represents the first phase of a long-term plan to bring Gelteq's proprietary gel delivery technology (搜索) to large-scale US manufacturing and global distribution.
Manufacturing and Distribution Framework
Under the MoU, Healthy Extracts will leverage its established US-based nutritional manufacturing capabilities to produce new gel-based nutraceutical products (搜索) using Gelteq's proprietary formulations, technical processes, and expertise. The partnership enables both companies to combine complementary strengths: Gelteq's innovation in gel-delivery science and Healthy Extracts' operational manufacturing excellence and market access.
New gel-based nutraceutical products (搜索) will be end-to-end manufactured in the United States using Healthy Extracts' in-house capabilities and then distributed across both domestic and international channels. This structure is designed to support rapidly scalable production, strengthen supply-chain reliability, and meet the growing global demand for novel, science-backed delivery formats in the nutrition category.
Healthy Extracts will serve as the primary manufacturer, commercial seller, and distribution partner for this range of products, with the opportunity available to white-label finished goods for select customers. Gelteq will provide the required technical transfer to enable manufacturing whilst retaining full ownership of its intellectual property. Both companies will collaborate on marketing initiatives and future product development.
Executive Perspectives on Market Expansion
"This partnership marks a significant step in expanding the reach of our gel-based technologies," said Nathan Givoni, CEO of Gelteq. "Healthy Extracts brings the manufacturing strength and market presence needed to introduce new gel-format nutraceuticals at scale. We're thrilled to see our technology applied to new product categories and new global markets."
Don Swanson, CEO of Healthy Extracts, emphasized the strategic value of the collaboration: "This MoU expands our product pipeline with next-generation gel-based nutraceuticals and establishes a clear pathway to scalable U.S. manufacturing and commercial execution. We intend to accelerate product rollout, broaden distribution across multiple channels, and support longer-term international expansion, as well as collaborate on additional product development, strategic commercialization initiatives, and expanded market opportunities over time."
Technology Platform and Market Positioning
As global demand increases for advanced nutraceutical delivery systems, the companies believe gel-based formats represent one of the next major growth frontiers in functional nutrition. With Healthy Extracts' manufacturing infrastructure and Gelteq's proprietary technology, the partnership establishes a pathway to commercialize multiple lines of gel-based products while also opening opportunities for joint expansion into new regions such as China and emerging wellness markets.
Gelteq, headquartered in Melbourne, Australia and traded on NASDAQ under the symbol GELS, is a biotechnology company that has developed a novel drug delivery platform in an ingestible gel form. The company specializes in the formulation, development and manufacturing of gel products for licensed partners across pharmaceutical, consumer health and animal health markets. The proprietary formulation technology aims to address challenges associated with conventional drug and nutrient delivery by enhancing bioavailability, improving patient compliance, and enabling precise dosing.
Healthy Extracts Inc. (搜索), traded on OTCQB under the symbol HYEX, develops, manufactures and markets proprietary, science-based supplements for brain, heart, and gut health. The platform operates as a vertically integrated NutraTech platform leveraging patented oral delivery technologies and strategic acquisitions to scale health and pharmaceutical-adjacent markets that deliver wellness solutions.
Following the signing of the MoU, the companies seek to finalize the full Manufacturing & Royalty Agreement and to formalize commercial terms.